0.8950.56% ( -0.005 )
Delay Closed: Nov 16, 16:08:00Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: DAWNRAYS PHARMA(02348) the Revenue is 315.23 M (-8.73%);the EBIT is 66.83 M (+12.78%);the EPS is 0.0474 (+24.21%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.32B8.73%
----
----
EBIT
0.07B12.78%
----
----
EPS
0.047424.21%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 27, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
